Medical Billing and Coding Healthcare Blog

The Centers for Medicare & Medicaid Services recently released its 2017 ambulatory surgery center (ASC) payment final rule.

There were a few changes worth noting, according to the national ASC Association (ASCA).

1. Payment increase. ASC payment rates will increase by 1.9%, which is larger than the 1.2% identified in the proposed rule.

2. Procedures added. Ten new procedures were added to the ASC list of payable procedures for 2017. They are as follows:

  • 20936 (Sp bone agrft local add-on)
  • 20937 (Sp bone agrft morsel add-on)
  • 20938 (Sp bone agrft struct add-on)
  • 22552 (Addl neck spine fusion)
  • 22840 (Insert spine fixation device)
  • 22842 (Insert spine fixation device)
  • 22851 (Apply spine prosth device)
  • 22853 (Insertion of interbody biomechanical device(s))
  • 22854 (Insertion of intervertebral biomechanical device(s))
  • 22859 (Insertion of intervertebral biomechanical device(s))

Unfortunately, as ASCA notes, "... these codes are add-on codes, and thus will not be separately payable when performed in the ASC."

3. Comments sought on total knee arthroplasty. CMS has requested public comments on whether CPT code 27447 (total knee arthroplasty) should be removed from the inpatient-only list. ASCA noted it has advocated for the code's removal from the inpatient-only list and will continue to do so.

4. Measures added. Seven new measures will be added for 2020 payment determinations. They are as follows:

  • ASC-13: Normothermia Outcome
  • ASC-14: Unplanned Anterior Vitrectomy
  • ASC-15a: OAS CAHPS – About Facilities and Staff
  • ASC- 15b: OAS CAHPS – Communication About Procedure
  • ASC-15c: OAS CAHPS – Preparation for Discharge and Recovery
  • ASC-15d: OAS CAHPS – Overall Rating of Facility
  • ASC-15e: OAS CAHPS – Recommendation of Facility

In December, ASCA will host a webinar on "Understanding Medicare's 2017 Final Payment Rule." For more details, click here.

The Centers for Medicare & Medicaid Services (CMS) has released a new provider compliance fact sheet concerning laboratory billing.

More specifically, the fact sheet concerns requisitions or orders for urine drug screening laboratory tests.

The fact sheet noted that a HHS report revealed "laboratory tests – other," which includes drug screenings, had an improper payment rate of 39 percent, and accounted for a projected $1.2 billion in Medicare fee-for-service improper payments. A vast majority of improper payments due to insufficient documentation.

The reasons for denials were as follows:

  1. Insufficient or no documentation to support the intent to order the test
  2. Insufficient or no documentation to support the medical necessity for the test of the individual patient
  3. Unsigned medical record documentation by the treating physician or non-physician practitioner

To prevent denials, CMS indicates the following conditions must be met:

  • Urine drug screenings must be ordered by the physician who is treating the beneficiary, that is, the physician and other eligible professionals who furnishes a consultation or treats a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary's specific medical problem. Tests not ordered by the physician who is treating the beneficiary are not reasonable and necessary.
  • All diagnostic x-ray tests, diagnostic laboratory tests and other diagnostic tests must be ordered for the treatment of the individual patient. Criteria to establish medical necessity for drug testing must be based on patient-specific elements identified during the clinical assessment and documented by the clinician in the patient's medical record. Tests used for routine screening of patients without regard to their individual need are not usually covered by the Medicare program, and therefore are not reimbursed.
  • The physician or other eligible professionals who ordered the test must maintain documentation of medical necessity in the beneficiary's medical record.
  • Entities submitting a claim must maintain documentation received from the ordering physician or non-physician practitioner.

Examples of documentation that may be requested for medical review of claims for laboratory tests, including urine drug screenings are:

  • Clinical evaluations, physician evaluations, consultations, progress notes, physician's office records, hospital records, nursing home records, home health agency records, records from other healthcare professionals and test reports. This documentation is maintained by the physician and/or provider.
  • Supplier/laboratory notes include all documents that are submitted by suppliers and laboratories in support of the claim.
  • Other documents include any records needed from a biller in order to conduct a review and reach a conclusion about the claim.

Orders

An order may be delivered via the following forms of communication:

  • A written document signed by the treating physician/eligible professionals, which is hand-delivered, mailed or faxed to the testing facility. Although no signature is required on orders for clinical diagnostic tests paid on the basis of the clinical laboratory fee schedule, the physician fee schedule, or for physician pathology services, documentation in the medical record must show intent to order and medical necessity for the testing.
  • A telephone call by the treating physician/eligible professional or his/her office to the testing facility.
  • An electronic mail by the treating physician/eligible professional or his/her office to the testing facility.

If the order is communicated via telephone, both the treating physician/eligible professional or his/her office and the testing facility must document the telephone call in their respective copies of the beneficiary's medical records. While a physician/eligible professional order is not required to be signed, the physician/eligible professional must clearly document, in the medical record, his or her intent that the test be performed.

In the compliance fact sheet, CMS also shares resources to help providers avoid improper laboratory medical billing payments.

X